Oregon Public Employees Retirement Fund acquired a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 28,167 shares of the company’s stock, valued at approximately $1,391,000.
Several other hedge funds also recently modified their holdings of the company. Dimensional Fund Advisors LP increased its stake in shares of Acadia Healthcare by 1.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 609,118 shares of the company’s stock valued at $20,165,000 after buying an additional 8,635 shares during the period. Guggenheim Capital LLC increased its stake in shares of Acadia Healthcare by 637.2% in the fourth quarter. Guggenheim Capital LLC now owns 43,088 shares of the company’s stock valued at $1,426,000 after buying an additional 37,243 shares during the period. Norges Bank bought a new stake in shares of Acadia Healthcare during the fourth quarter valued at approximately $8,410,000. Quadrature Capital Ltd bought a new stake in shares of Acadia Healthcare during the fourth quarter valued at approximately $406,000. Finally, Teachers Advisors LLC increased its stake in shares of Acadia Healthcare by 0.6% in the fourth quarter. Teachers Advisors LLC now owns 368,685 shares of the company’s stock valued at $12,203,000 after buying an additional 2,026 shares during the period.
Shares of Acadia Healthcare Company, Inc. (ACHC) traded down 0.19% during trading on Friday, reaching $46.90. The company’s stock had a trading volume of 2,127,576 shares. The company has a market capitalization of $4.12 billion, a price-to-earnings ratio of 515.38 and a beta of 1.15. Acadia Healthcare Company, Inc. has a one year low of $32.54 and a one year high of $54.34. The firm’s 50-day moving average price is $50.51 and its 200-day moving average price is $45.06.
Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Thursday, July 27th. The company reported $0.66 EPS for the quarter, topping the consensus estimate of $0.65 by $0.01. The firm had revenue of $715.90 million during the quarter, compared to analyst estimates of $717.38 million. Acadia Healthcare had a return on equity of 8.69% and a net margin of 0.30%. Acadia Healthcare’s revenue was down 5.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.73 EPS. On average, equities analysts anticipate that Acadia Healthcare Company, Inc. will post $2.45 earnings per share for the current year.
TRADEMARK VIOLATION WARNING: This story was first posted by BNB Daily and is the sole property of of BNB Daily. If you are reading this story on another site, it was stolen and reposted in violation of United States and international trademark & copyright law. The original version of this story can be viewed at https://www.baseball-news-blog.com/2017/08/19/oregon-public-employees-retirement-fund-invests-1-39-million-in-acadia-healthcare-company-inc-achc-updated-updated.html.
Several analysts have recently commented on ACHC shares. Cantor Fitzgerald reissued a “hold” rating and issued a $45.00 price objective on shares of Acadia Healthcare in a research note on Wednesday, April 26th. Zacks Investment Research raised Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Friday, April 28th. Jefferies Group LLC reaffirmed a “buy” rating on shares of Acadia Healthcare in a research report on Friday, May 5th. Leerink Swann downgraded Acadia Healthcare from an “outperform” rating to a “market perform” rating in a research report on Monday, May 15th. Finally, KeyCorp reaffirmed an “overweight” rating and set a $51.00 price target on shares of Acadia Healthcare in a research report on Thursday, June 1st. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $59.21.
In other news, Director Reeve B. Waud sold 1,240,000 shares of the company’s stock in a transaction on Monday, July 31st. The stock was sold at an average price of $51.72, for a total value of $64,132,800.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director William Grieco sold 2,000 shares of the company’s stock in a transaction on Friday, June 16th. The stock was sold at an average price of $45.42, for a total value of $90,840.00. Following the completion of the sale, the director now owns 47,013 shares of the company’s stock, valued at $2,135,330.46. The disclosure for this sale can be found here. Insiders sold a total of 2,138,347 shares of company stock valued at $105,486,669 over the last 90 days. 11.10% of the stock is currently owned by company insiders.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.